Is a stock with high projected EPS growth a red flag?

I'm analyzing a stock with good growth drivers, in the emerging market movie space.

Everything looks good, except the projected consensus EPS growth rate for the new few years is about 40% each year. One thing to note is that it is based on only 3 analysts as its not well covered. Market cap of 1B USD.

In general, would it be tough to pitch a company with such a high consensus EPS growth figure?

 

Why are you pitching the consensus growth figure? Do you work for one of the firms making up the consensus?

What the consensus thinks isn't near as important as what you think. Ignore the consensus while drawing up your own conclusion. Then figure out where you differ, and when you pitch the stock, be clear on where you're more bullish / more bearish.

To directly answer your question: No, pitching a stock with a high EPS growth figure isn't tough if a) there are clear reasons for the high growth, and b) valuations are still reasonable.

- If you think hiring a professional is expensive, wait until you've hired an amateur
 

Thanks for your thoughts. But if I think the growth drivers will yield similar growth rates, and don't have anything extra on top of that, then I should walk away considering the consensus is already predicting 40% EPS growth right?

Side question: If the three analysts providing the forecasts are predicting a 35% upside for the stock, does that mean that the 40% EPS growth is not the actual market consensus, and I would be OK with predicting a similar or slightly lower growth figure?

 
Best Response

Et ipsum id quia vel eaque ipsa perferendis quasi. Dolorem laboriosam iure ea voluptatibus nesciunt minus qui.

Quis qui quidem est animi tempora. Quibusdam tempore sit voluptas doloremque dolor odio quo. Molestiae aut sit maiores sit est autem.

Voluptatem voluptates fugiat et rerum praesentium. Corrupti repellendus voluptatum impedit repellendus. Deleniti numquam corrupti odit corporis cumque. Deserunt beatae fuga delectus dolores minima eos est quibusdam. Accusamus nemo fugiat et doloremque.

Accusamus delectus non quia. Recusandae id rerum occaecati.

Career Advancement Opportunities

March 2024 Investment Banking

  • Jefferies & Company 02 99.4%
  • Goldman Sachs 19 98.8%
  • Harris Williams & Co. (++) 98.3%
  • Lazard Freres 02 97.7%
  • JPMorgan Chase 03 97.1%

Overall Employee Satisfaction

March 2024 Investment Banking

  • Harris Williams & Co. 18 99.4%
  • JPMorgan Chase 10 98.8%
  • Lazard Freres 05 98.3%
  • Morgan Stanley 07 97.7%
  • William Blair 03 97.1%

Professional Growth Opportunities

March 2024 Investment Banking

  • Lazard Freres 01 99.4%
  • Jefferies & Company 02 98.8%
  • Goldman Sachs 17 98.3%
  • Moelis & Company 07 97.7%
  • JPMorgan Chase 05 97.1%

Total Avg Compensation

March 2024 Investment Banking

  • Director/MD (5) $648
  • Vice President (19) $385
  • Associates (86) $261
  • 3rd+ Year Analyst (13) $181
  • Intern/Summer Associate (33) $170
  • 2nd Year Analyst (66) $168
  • 1st Year Analyst (202) $159
  • Intern/Summer Analyst (144) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”